Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Inv. presentation

Akero Therapeutics, Inc. (AKRO) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 4 Cheng Andrew (President and CEO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 8,868 shares @ $46.057, valued at $408.4k
Sold 5,300 shares @ $46.8836, valued at $248.5k
Sold 2,662 shares @ $48.5632, valued at $129.3k
Sold 1,700 shares @ $49.7059, valued at $84.5k
Sold 6,470 shares @ $50.5619, valued at $327.1k
Exercised 25,000 options to buy @ $6.36, valued at $159k
10/04/2023 4 Young Jonathan (COO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 490 shares @ $51.1, valued at $25k
Exercised 490 options to buy @ $21.1, valued at $10.3k
08/10/2023 4 Graham G. Walmsley (Director) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Bought 25,000 shares @ $42.059, valued at $1.1M
08/03/2023 4 Cheng Andrew (President and CEO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 13,679 shares @ $42.8514, valued at $586.2k
Sold 11,321 shares @ $43.5211, valued at $492.7k
Exercised 25,000 options to buy @ $6.36, valued at $159k
08/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/06/2023 4 Cheng Andrew (President and CEO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 18,730 shares @ $44.6606, valued at $836.5k
Sold 5,051 shares @ $45.3615, valued at $229.1k
Sold 1,219 shares @ $46.2896, valued at $56.4k
Exercised 25,000 options to buy @ $6.36, valued at $159k
06/15/2023 4 White William Richard (CFO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 606 shares @ $55.16, valued at $33.4k
06/15/2023 4 Cheng Andrew (President & CEO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 1,613 shares @ $55.16, valued at $89k
06/15/2023 4 Rolph Timothy (Chief Scientific Officer) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 509 shares @ $55.16, valued at $28.1k
06/15/2023 4 Young Jonathan (COO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 538 shares @ $55.16, valued at $29.7k
06/15/2023 4 Yale Catriona (Chief Development Officer) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 591 shares @ $55.16, valued at $32.6k
06/15/2023 4/A Graham G. Walmsley (Director) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Bought 400,000 shares @ $26, valued at $10.4M
Bought 120,000 shares @ $42, valued at $5M
06/05/2023 4 Cheng Andrew (President and CEO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 3,914 shares @ $44.1752, valued at $172.9k
Sold 20,686 shares @ $45.2562, valued at $936.2k
Sold 400 shares @ $45.897, valued at $18.4k
Exercised 21,330 options to buy @ $0.615, valued at $13.1k
Exercised 3,670 options to buy @ $6.36, valued at $23.3k
05/23/2023 4 Graham G. Walmsley (Director) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Bought 400,000 shares @ $26, valued at $10.4M
Bought 120,000 shares @ $42, valued at $5M
05/03/2023 4 Cheng Andrew (President & CEO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 21,523 shares @ $45.0049, valued at $968.6k
Sold 3,477 shares @ $45.5045, valued at $158.2k
Exercised 40,000 options to buy @ $0.615, valued at $24.6k
Exercised 25,000 options to buy @ $0.615, valued at $15.4k
04/05/2023 4 Cheng Andrew (President & CEO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 23,292 shares @ $37.8783, valued at $882.3k
Sold 1,708 shares @ $38.8259, valued at $66.3k
Exercised 25,000 options to buy @ $0.615, valued at $15.4k
03/14/2023 4 White William Richard (CFO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Paid exercise price by delivering 641 shares @ $43.47, valued at $27.9k
03/14/2023 4 Yale Catriona (Chief Development Officer) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Paid exercise price by delivering 701 shares @ $43.46, valued at $30.5k
03/14/2023 4 Young Jonathan (COO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Paid exercise price by delivering 634 shares @ $43.47, valued at $27.6k
03/14/2023 4 Rolph Timothy (Chief Scientific Officer) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Paid exercise price by delivering 603 shares @ $43.47, valued at $26.2k
03/14/2023 4 Cheng Andrew (President & CEO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Paid exercise price by delivering 1,706 shares @ $43.47, valued at $74.2k
02/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/18/2023 4 Yale Catriona (Chief Development Officer) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 1,048 shares @ $49.1187, valued at $51.5k
Sold 1,534 shares @ $49.8901, valued at $76.5k
Sold 1,313 shares @ $51.1784, valued at $67.2k
Sold 1,105 shares @ $51.987, valued at $57.4k
01/11/2023 4 Lamy Patrick (See Remarks) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Granted 100,000 options to buy @ $44.37, valued at $4.4M
01/11/2023 3 Lamy Patrick (See Remarks) has filed a Form 3 on Akero Therapeutics, Inc.
01/05/2023 4 Cheng Andrew (President & CEO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 13,200 shares @ $50.1199, valued at $661.6k
Sold 3,800 shares @ $50.8194, valued at $193.1k
Sold 3,000 shares @ $52.0319, valued at $156.1k
Sold 800 shares @ $53.0878, valued at $42.5k
Sold 3,900 shares @ $54.371, valued at $212k
Sold 300 shares @ $54.8067, valued at $16.4k
Exercised 25,000 options to buy @ $0.615, valued at $15.4k
01/05/2023 4 Young Jonathan (COO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 8,777 shares @ $54.6383, valued at $479.6k
Exercised 8,777 options to buy @ $0.615, valued at $5.4k
12/30/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/29/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/28/2022 4 Young Jonathan (COO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 12,500 shares @ $49.5687, valued at $619.6k
Exercised 11,778 options to buy @ $6.36, valued at $74.9k
Exercised 722 options to buy @ $0.615, valued at $444
12/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/20/2022 4 Young Jonathan (COO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Granted 29,073 options to buy @ $21.1, valued at $613.4k
12/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy